Cue Biopharma (CUE) Other Operating Expenses (2022 - 2025)

Cue Biopharma has disclosed Other Operating Expenses across 4 years of filings, most recently posting -$20000.0 for Q4 2025.

• Other Operating Expenses for Q4 2025 came in at -$20000.0, down 400.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $31000.0 (down 66.67% YoY), and the FY2025 annual result was -$31000.0, down 133.33% from the prior year.
• Other Operating Expenses came in at -$20000.0 for Q4 2025 at Cue Biopharma, down from $51000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $97000.0 in Q3 2024 to a low of -$258000.0 in Q2 2022.
• The 4-year median for Other Operating Expenses is -$19000.0 (2022), against an average of -$44285.7.
• Across the five-year window, Other Operating Expenses plunged 726.32% in 2023 and jumped 97.45% in 2024, its largest moves.
• Cue Biopharma's Other Operating Expenses stood at -$19000.0 in 2022, then slumped by 726.32% to -$157000.0 in 2023, then surged by 97.45% to -$4000.0 in 2024, then plunged by 400.0% to -$20000.0 in 2025.
• The last three Other Operating Expenses figures came in at -$20000.0 (Q4 2025), $51000.0 (Q3 2025), and -$4000.0 (Q4 2024), per Business Quant data.